Understanding increased ferritin levels in pediatric ECMO patients

Area of Science:

• Biochemistry
• Pediatric Critical Care
• Hematology

Background:

• Elevated serum ferritin is observed in pediatric patients during extracorporeal membrane oxygenation (ECMO).
• Ferritin is often linked to iron overload due to frequent red blood cell transfusions in ECMO patients.
• However, ferritin also acts as an acute-phase reactant, complicating its diagnostic utility for iron overload.

Purpose of the Study:

• To evaluate the effectiveness of serum ferritin as a biomarker for diagnosing iron overload in pediatric ECMO patients.
• To explore the relationship between ferritin levels, inflammation, and erythropoiesis during ECMO.
• To investigate the role of erythropoietin (EPO) in this context.

Main Methods:

• Analysis of serum ferritin, serum iron, interleukin-6 (IL-6), and erythropoietin (EPO) levels in pediatric ECMO patients.
• Correlation analysis to assess relationships between these biomarkers.
• Comparison of ferritin levels with iron status and inflammatory markers.

Main Results:

• Ferritin was elevated in all pediatric ECMO cases (median 459 ng/ml).
• Serum iron levels showed intermittent elevations but normalized before ECMO cessation.
• Ferritin demonstrated a weak correlation with serum iron (r=0.05, p=0.65) but strong correlations with IL-6 (r=0.48, p<0.001) and EPO (r=0.55, p<0.001).
• Erythropoietin levels remained high throughout ECMO despite transfusions and hyperoxia.

Conclusions:

• Serum ferritin is an unreliable biomarker for diagnosing iron overload in pediatric ECMO patients.
• Ferritin levels during ECMO are significantly influenced by inflammatory markers like IL-6 and erythropoiesis markers like EPO.
• Further research is needed to understand the complex interplay between ferritin, EPO, and iron metabolism in ECMO patients.